Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boston Scientific
BSX
|
+$240M |
| 2 |
eBay
EBAY
|
+$231M |
| 3 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$216M |
| 4 |
Ameren
AEE
|
+$196M |
| 5 |
Kohl's
KSS
|
+$182M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$552M |
| 2 |
Micron Technology
MU
|
+$425M |
| 3 |
Visa
V
|
+$225M |
| 4 |
Marathon Petroleum
MPC
|
+$225M |
| 5 |
ESRX
Express Scripts Holding Company
ESRX
|
+$218M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.17% |
| 2 | Healthcare | 12.72% |
| 3 | Technology | 12.27% |
| 4 | Industrials | 11.44% |
| 5 | Consumer Discretionary | 11.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NVMI
2376
Nova
NVMI
$11.7B
| $1.76M | ﹤0.01% |
64,858
+56,339
| +661% | +$1.54M |
|
|
ESTR
2377
DELISTED
Estre Ambiental, Inc.
ESTR
| $1.76M | ﹤0.01% |
+175,820
| New | +$1.71M |
|
|
ABLX
2378
DELISTED
Ablynx NV
ABLX
| $1.75M | ﹤0.01% |
32,147
-483,142
| -94% | -$23.9M |
|
2379
eGain
EGAN
$197M
| $1.75M | ﹤0.01% |
219,927
+145,881
| +197% | +$968K |
|
2380
First Trust Global Tactical Commodity Strategy Fund
FTGC
$3.19B
| $1.75M | ﹤0.01% |
83,721
-29,014
| -26% | -$604K |
|
|
SP
2381
DELISTED
SP Plus Corporation
SP
| $1.75M | ﹤0.01% |
49,064
-49,300
| -50% | -$1.85M |
|
2382
Kroger
KR
$35.8B
| $1.74M | ﹤0.01% |
72,810
-719,022
| -91% | -$19.5M |
|
2383
KT
KT
$9.36B
| $1.74M | ﹤0.01% |
127,217
-278,681
| -69% | -$3.98M |
|
2384
Cavco Industries
CVCO
$4.44B
| $1.74M | ﹤0.01% |
9,995
-1,277
| -11% | -$211K |
|
2385
Invesco Preferred ETF
PGX
$3.73B
| $1.74M | ﹤0.01% |
118,883
+72,546
| +157% | +$1.06M |
|
|
MTSC
2386
DELISTED
MTS Systems Corp
MTSC
| $1.74M | ﹤0.01% |
33,600
-71,687
| -68% | -$3.71M |
|
2387
J. Jill
JILL
$297M
| $1.72M | ﹤0.01% |
92,564
+15,108
| +20% | +$484K |
|
|
ATRI
2388
DELISTED
Atrion Corp
ATRI
| $1.72M | ﹤0.01% |
2,719
+1,935
| +247% | +$1.13M |
|
|
ECYT
2389
DELISTED
Endocyte, Inc. Common Stock
ECYT
| $1.72M | ﹤0.01% |
188,931
-135,095
| -42% | -$745K |
|
|
CGNT
2390
DELISTED
Cogentix Medical, Inc.
CGNT
| $1.72M | ﹤0.01% |
446,048
+341,705
| +327% | +$1.07M |
|
2391
FedEx
FDX
$79.5B
| $1.71M | ﹤0.01% |
7,120
-298,516
| -98% | -$75.5M |
|
|
MYOK
2392
CALL
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $1.71M | ﹤0.01% |
+35,000
| New | +$1.82M |
|
|
RSO
2393
DELISTED
Resource Capital Corp.
RSO
| $1.71M | ﹤0.01% |
179,361
-51,856
| -22% | -$479K |
|
2394
CALL
Amgen
AMGN
$238B
| $1.71M | ﹤0.01% |
+10,000
| New | +$1.84M |
|
|
PETQ
2395
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
| $1.7M | ﹤0.01% |
64,022
-96,245
| -60% | -$2.25M |
|
2396
iShares MSCI Switzerland ETF
EWL
$2.44B
| $1.7M | ﹤0.01% |
49,526
+9,336
| +23% | +$332K |
|
2397
Q32 Bio
QTTB
$482M
| $1.7M | ﹤0.01% |
+5,051
| New | +$1.7M |
|
|
PTVCB
2398
DELISTED
Protective Insurance Corporation Class B Common Stock
PTVCB
| $1.7M | ﹤0.01% |
77,110
+29,757
| +63% | +$692K |
|
|
RCM
2399
DELISTED
R1 RCM Inc. Common Stock
RCM
| $1.69M | ﹤0.01% |
+237,036
| New | +$1.33M |
|
|
CO
2400
DELISTED
Global Cord Blood Corporation
CO
| $1.68M | ﹤0.01% |
164,781
+54,406
| +49% | +$556K |
|
Similar funds
Israel Englander's Q1 2018 Portfolio in Review
As of Q1 2018, Israel Englander held 4,417 positions worth $74.9B, up 3.4% from $72.5B the previous quarter. Its ten largest holdings account for 6.3% of the portfolio.
Israel Englander deployed $3.29B of net new capital in Q1 2018, opening 664 new positions and adding to 1,466 existing holdings. Its largest new stake was Tiffany & Co.: 1,078,847 shares worth $105M.
By sector, the portfolio is most concentrated in Financials at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $552M trimmed.
- Israel Englander's largest Q1 2018 buy was Tiffany & Co.: 1,078,847 shares worth $105M.
- Israel Englander added most to Boston Scientific in Q1 2018, an estimated $240M increase.
- Israel Englander's biggest Q1 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $552M.
- Israel Englander fully exited Equinix in Q1 2018, selling an estimated $152M.
- Israel Englander's ten largest holdings make up 6.3% of its $74.9B portfolio in Q1 2018.
- Israel Englander opened 664 new positions and closed 833 in Q1 2018.
- Israel Englander's portfolio value rose 3.4% quarter-over-quarter to $74.9B.
Based on Millennium Management's 13F filing for Q1 2018, filed 15 May 2018.